Background: Psychostimulants and opiates trigger similar enduring neuroadaptations within the reward circuitry thought to underlie addiction. Transcription factors are key to mediating these enduring behavioral alterations. The facilitation of these maladaptive changes by glucocorticoid hormones suggests that the glucocorticoid receptor (GR), a transcription factor involved in the stress response, could be a common mediator of responses to pharmacologically distinct classes of abused drugs.

Methods: We employed mouse models carrying GR gene inactivation in either dopamine or dopaminoceptive neurons to determine the involvement of this transcription factor in behavioral responses to cocaine and morphine. We then combined microarray analysis, drug-elicited immediate early gene induction, and in vivo microdialysis to elucidate the molecular underpinnings of these responses.

Results: Inactivating GR within dopaminoceptive neurons markedly reduces cocaine-induced conditioned place preference and the expression of locomotor sensitization. In striking contrast, GR had no effect on behavioral morphine responses in either dopaminoceptive or dopamine neurons. The dopaminoceptive mutation engenders alterations in the expression of striatal genes that are implicated in glutamatergic transmission and plasticity. Within the nucleus accumbens, impaired cellular responses to cocaine are conspicuous; a pronounced deficit in cocaine-elicited extracellular dopamine release, expression of the key IEGs c-Fos and Zif268, and phosphorylation of extracellular signal-regulated kinases 1/2 in mutants were observed. In contrast, these molecular and neurochemical changes were not observed in response to morphine, mirroring the lack of effect on behavioral responses to morphine.

Conclusion: Combined behavioral and molecular approaches have identified a subset of neurons in which GR differentially influences cocaine- and morphine-induced responses.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biopsych.2010.03.037DOI Listing

Publication Analysis

Top Keywords

dopaminoceptive neurons
12
behavioral morphine
8
morphine responses
8
transcription factor
8
behavioral responses
8
responses cocaine
8
responses
7
behavioral
6
dopaminoceptive
5
neurons
5

Similar Publications

The ventral pallidum (VP) is critical for motivated behaviors. While contemporary work has begun to elucidate the functional diversity of VP neurons, the molecular heterogeneity underlying this functional diversity remains incompletely understood. We used single-nucleus RNA sequencing and in situ hybridization to define the transcriptional taxonomy of VP cell types in mice, macaques, and baboons.

View Article and Find Full Text PDF

New MiniPromoter Ple389 (ADORA2A) drives selective expression in medium spiny neurons in mice and non-human primates.

Sci Rep

November 2024

Centre for Molecular Medicine and Therapeutics at British Columbia Children's Hospital, The University of British Columbia, 2028-950 West 28th Avenue, Vancouver, BC, V5Z 4H4, Canada.

Compact cell type-specific promoters are important tools for basic and preclinical research and clinical delivery of gene therapy. In this work, we designed novel MiniPromoters to target D1 and D2 type dopaminoceptive medium spiny neurons in the striatum by manually identifying candidate regulatory regions or employing the OnTarget webserver. We then empirically tested the designs in rAAV-PHP.

View Article and Find Full Text PDF

Dopamine stimulates CDP-diacylglycerol biosynthesis through D-like receptors, particularly the D subtype most of which is intracellularly localized. CDP-diacylglycerol regulates phosphatidylinositol-4,5-bisphosphate-dependent signaling cascades by serving as obligatory substrate for phosphatidylinositol biosynthesis. Here, we used acute and organotypic brain tissues and cultured cells to explore the mechanism by which extracellular dopamine acts to modulate intracellular CDP-diacylglycerol.

View Article and Find Full Text PDF
Article Synopsis
  • Researchers used an advanced technique called RNAScope to measure the levels of three dopamine receptors (Drd1, Drd2, Drd3) in specific brain regions related to song control in male and female canaries, who were treated with testosterone to promote singing activity.
  • The study found that all receptor types were present in the various regions, except Drd3 in Area X, but there were very few noticeable differences between male and female canaries regarding dopamine receptor expression, which did not account for the differences in song.
  • The majority of dopamine receptor-expressing cells in the HVC area were linked to excitatory markers, while the PAG had lower receptor density and fewer inhibitory cells, and activation of these cells during
View Article and Find Full Text PDF
Article Synopsis
  • Gestational exposure to valproic acid (VPA) in rodents creates a model that reflects behavioral deficits seen in human autism spectrum disorder (ASD), particularly reduced sociability.
  • Previous studies indicated that VPA treatment resulted in specific changes in the brain's dopaminergic pathways, particularly affecting dopamine levels in certain areas but not others.
  • The latest research used advanced imaging techniques to analyze the connections between dopaminergic axons and specific neuronal markers in key brain regions, revealing reduced synaptic interactions and changes in neuron populations in VPA treated mice.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!